Actionnariat et activité des initiés pour Immunovant, Inc. (IMVT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $36.38 |
| Capitalisation | $7.5B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-28 | Pande Atul | M-Exempt | 1,500 | $13K |
| 2026-08-28 | Pande Atul | S-Sale | 1,500 | $65K |
| 2026-08-28 | Pande Atul | M-Exempt | 1,500 | $13K |
| 2026-08-20 | Gloria Melanie | S-Sale | 3,056 | $135K |
| 2026-07-24 | Pande Atul | M-Exempt | 1,500 | $13K |
| 2026-07-24 | Pande Atul | S-Sale | 1,500 | $60K |
| 2026-07-24 | Pande Atul | M-Exempt | 1,500 | $13K |
| 2026-07-23 | Girao Tiago | S-Sale | 6,798 | $263K |
| 2026-07-23 | Stout Jay S | S-Sale | 2,857 | $111K |
| 2026-07-08 | Gloria Melanie | S-Sale | 1,930 | $76K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | 0 | $325000 | $100.6M | $400.1M | $493.8M | $376.5M | $635.4M | $714.0M | $902.1M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | 0 | $3.0M | $1.1M | $12.9M | $885000 | $5.5M | $2.5M | $3.9M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $113170 | $325000 | $109.1M | $409.0M | $512.9M | $404.3M | $665.8M | $767.7M | $948.8M |
| Immobilisations Corporelles | 0 | 0 | $65000 | $3.5M | $2.6M | $1.5M | $595000 | $942000 | $515000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $113170 | $405000 | $109.4M | $412.5M | $515.6M | $405.8M | $666.7M | $776.2M | $957.6M |
| Dettes Fournisseurs | $1.1M | 0 | $1.2M | $2.4M | $18.6M | $1.4M | $7.2M | $17.7M | $7.5M |
| Dette à Court Terme | 0 | $300000 | $3.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.6M | $380448 | $15.3M | $18.8M | $44.5M | $43.3M | $48.6M | $68.8M | $104.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.6M | $380448 | $15.3M | $21.0M | $45.7M | $43.3M | $49.0M | $68.8M | $105.0M |
| Réserves | 0 | -$448 | -$91.2M | -$198.7M | -$355.4M | -$566.3M | -$825.7M | -$1.24B | -$1.75B |
| Capitaux Propres | -$1.5M | $24552 | $94.1M | $391.5M | $469.8M | $362.5M | $617.8M | $707.4M | $852.6M |
| Dette Totale | 0 | $300000 | $3.2M | $3.4M | $2.4M | $1.2M | $138000 | $98000 | $72000 |
| Dette Nette | 0 | -$25000 | -$97.4M | -$396.7M | -$491.5M | -$375.3M | -$635.2M | -$713.9M | -$902.0M |
| Fonds de Roulement | -$1.5M | -$55448 | $93.8M | $390.2M | $468.4M | $361.0M | $617.2M | $698.9M | $844.4M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 7.27 |
Rentabilité
| Marge brute | 97.10% |
| Marge opérationnelle | -7877.46% |
| Marge nette | -7585.86% |
Entreprises liées: ACAD · AKRO · CRNX · DYN · KYMR · NAMS · PRAX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de IMVT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions